These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 29230413)

  • 1. Establishment and Application of Prostate Cancer Circulating Tumor Cells in the Era of Precision Medicine.
    Suh YS; Joung JY; Kim SH; Seo HK; Chung J; Lee KH
    Biomed Res Int; 2017; 2017():7206307. PubMed ID: 29230413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic cancer circulating tumor cells: applications for personalized oncology.
    DiPardo BJ; Winograd P; Court CM; Tomlinson JS
    Expert Rev Mol Diagn; 2018 Sep; 18(9):809-820. PubMed ID: 30099926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Application of Liquid Biopsies in Metastatic Prostate Cancer.
    Morrison GJ; Goldkorn A
    Curr Oncol Rep; 2018 Mar; 20(4):35. PubMed ID: 29572775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of circulating tumor cells from peripheral blood in prostate cancer].
    Thalgott M; Heck MM; Pantel K
    Urologe A; 2014 Apr; 53(4):509-13. PubMed ID: 24671249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.
    Casanova-Salas I; Athie A; Boutros PC; Del Re M; Miyamoto DT; Pienta KJ; Posadas EM; Sowalsky AG; Stenzl A; Wyatt AW; Mateo J
    Eur Urol; 2021 Jun; 79(6):762-771. PubMed ID: 33422353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancer.
    Soekmadji C; Corcoran NM; Oleinikova I; Jovanovic L; ; Ramm GA; Nelson CC; Jenster G; Russell PJ
    Prostate; 2017 Oct; 77(14):1416-1423. PubMed ID: 28856701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell analysis of CTCs with diagnostic precision: opportunities and challenges for personalized medicine.
    Alberter B; Klein CA; Polzer B
    Expert Rev Mol Diagn; 2016; 16(1):25-38. PubMed ID: 26567956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis.
    Court CM; Ankeny JS; Hou S; Tseng HR; Tomlinson JS
    Expert Rev Mol Diagn; 2015; 15(11):1491-504. PubMed ID: 26390158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Studies on Viable Circulating Tumor Cells.
    Pantel K; Alix-Panabières C
    Clin Chem; 2016 Feb; 62(2):328-34. PubMed ID: 26637479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid biopsy: current technology and clinical applications.
    Nikanjam M; Kato S; Kurzrock R
    J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cells in breast cancer: applications in personalized medicine.
    Lee JS; Magbanua MJM; Park JW
    Breast Cancer Res Treat; 2016 Dec; 160(3):411-424. PubMed ID: 27761678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Innovations in personalized medicine : Molecular characterization of liquid biopsy-fake or fact?].
    Theil G; Fornara P
    Urologe A; 2018 Sep; 57(9):1069-1074. PubMed ID: 29971453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid biopsy in prostate cancer: current status and future challenges of clinical application.
    Wang Y; Wang Z; Gang X; Wang G
    Aging Male; 2021 Dec; 24(1):58-71. PubMed ID: 34850655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid Biopsy in Prostate Cancer: Circulating Tumor Cells and Beyond.
    Zainfeld D; Goldkorn A
    Cancer Treat Res; 2018; 175():87-104. PubMed ID: 30168118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer.
    Saad F; Pantel K
    Future Oncol; 2012 Mar; 8(3):321-31. PubMed ID: 22409467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook.
    Tinhofer I; Staudte S
    Expert Rev Mol Diagn; 2018 Oct; 18(10):897-906. PubMed ID: 30199647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-free and circulating tumor cell-based biomarkers in men with metastatic prostate cancer: Tools for real-time precision medicine?
    Miyamoto DT; Lee RJ
    Urol Oncol; 2016 Nov; 34(11):490-501. PubMed ID: 27771279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study.
    Zapatero A; Gómez-Caamaño A; Cabeza Rodriguez MÁ; Muinelo-Romay L; Martin de Vidales C; Abalo A; Calvo Crespo P; Leon Mateos L; Olivier C; Vega Piris LV
    Radiat Oncol; 2020 Jun; 15(1):137. PubMed ID: 32487218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cells in patients with lung cancer: developments and applications for precision medicine.
    Tong B; Wang M
    Future Oncol; 2019 Jul; 15(21):2531-2542. PubMed ID: 31339062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.